The SNEC Ophthalmic Technologies Incubator
The TD&C team oversees the operation of the SERI-SNEC ophthalmic technologies incubator. This framework is intended to facilitate the close, focused, flexible and rapid nurturing and development of a series of technologies which will later form a string of medical technology companies. Building on the continuously growing SERI IP portfolio, these start-up-oriented technology development projects give SERI a unique portfolio which has market attractiveness in a wide range of fields. Since 2014, four start-ups have emerged from R&D activities conducted at SERI, and we are working on a number of additional exciting technologies which we believe will have a substantial impact on their respective markets in coming years.
Subscribe to our mailing list to get the updates to your email inbox...
